Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Theravance Biopharma (TBPH) Shares Repurchased: 2022-2024

Historic Shares Repurchased for Theravance Biopharma (TBPH) over the last 1 years, with Mar 2024 value amounting to $445,000.

  • Theravance Biopharma's Shares Repurchased fell 99.20% to $445,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $142.1 million, marking a year-over-year change of. This contributed to the annual value of $445,000 for FY2024, which is 99.77% down from last year.
  • Theravance Biopharma's Shares Repurchased amounted to $445,000 in Q1 2024, which was down 98.53% from $30.3 million recorded in Q4 2023.
  • Over the past 5 years, Theravance Biopharma's Shares Repurchased peaked at $80.5 million during Q2 2023, and registered a low of $445,000 during Q1 2024.
  • Its 3-year average for Shares Repurchased is $38.7 million, with a median of $32.8 million in 2022.
  • Data for Theravance Biopharma's Shares Repurchased shows a maximum YoY tumbled of 99.20% (in 2024) over the last 5 years.
  • Theravance Biopharma's Shares Repurchased (Quarterly) stood at $34.8 million in 2022, then dropped by 13.02% to $30.3 million in 2023, then slumped by 99.20% to $445,000 in 2024.
  • Its Shares Repurchased was $445,000 in Q1 2024, compared to $30.3 million in Q4 2023 and $30.9 million in Q3 2023.